Abstract-The distribution of spinal primary afferent terminals labeled transganglionically with the choleratoxin B subunit (CTB) or its conjugates changes profoundly after perineural treatment with capsaicin. Injection of CTB conjugated with horseradish peroxidase (HRP) into an intact nerve labels somatotopically related areas in the ipsilateral dorsal horn with the exceptions of the marginal zone and the substantia gelatinosa, whereas injection of this tracer into a capsaicin-pretreated nerve also results in massive labeling of these most superficial layers of the dorsal horn. The present study was initiated to clarify the role of C-fiber primary afferent neurons in this phenomenon. In L5 dorsal root ganglia, analysis of the size frequency distribution of neurons labeled after injection of CTB-HRP into the ipsilateral sciatic nerve treated previously with capsaicin or resiniferatoxin revealed a significant increase in the proportion of small neurons. In the spinal dorsal horn, capsaicin or resiniferatoxin pretreatment resulted in intense CTB-HRP labeling of the marginal zone and the substantia gelatinosa. Electron microscopic histochemistry disclosed a dramatic, 10-fold increase in the proportion of CTB-HRP-labeled unmyelinated dorsal root axons following perineural capsaicin or resiniferatoxin. The present results indicate that CTB-HRP labeling of C-fiber dorsal root ganglion neurons and their central terminals after perineural treatment with vanilloid compounds may be explained by their phenotypic switch rather than a sprouting response of thick myelinated spinal afferents which, in an intact nerve, can be labeled selectively with CTB-HRP. The findings also suggest a role for GM1 ganglioside in the modulation of nociceptor function and pain. Ó
INTRODUCTION
Perineural treatment with capsaicin and other vanilloids has been shown to produce selective and long-lasting regional thermal and chemical analgesia and abolition of the neurogenic inflammatory response without affecting non-nociceptive sensory nerves, and autonomic efferent and motor nerves (Jancso´et al., 1980 (Jancso´et al., , 1985 (Jancso´et al., , 1987a Fitzgerald and Woolf, 1982; Gamse et al., 1982; Jancsoá nd Such, 1983; Chung et al., 1985; Jancso´and Ambrus, 1994; Kissin, 2008) . Capsaicin applied onto peripheral nerves produces this unique effect (which we term nociceptor analgesia) through selective action on nociceptive afferent nerves, although the exact mechanisms involved are not yet fully elucidated (Jancsoé t al., 1980 (Jancsoé t al., , 2011 Gibson et al., 1982; Petsche et al., 1983; Welk et al., 1983; Lynn and Pini, 1984; Jancsoá nd Lynn, 1987; Holzer, 1991) . The defunctionalization of primary afferent neurons which express the transient receptor potential vanilloid type 1 (TRPV1)/capsaicin receptor through the perineural application of capsaicin has become a well-established experimental strategy in pain research to study nociceptive and viscerosensory mechanisms (South and Ritter, 1988; Maggi et al., 1989; Holzer, 1991; Nagy et al., 2004; Jancso´and Sa´ntha, 2015) . Vanilloid-induced nociceptor analgesia may be produced in any area of the body by treating the corresponding nerve(s) in a variety of animal species (Gamse et al., 1982) , including primates (Chung et al., 1985) , and it has therefore been considered as a possible therapeutic approach for the relief of pain of peripheral or neuropathic origin (Jancso´et al., 1980 (Jancso´et al., , 2008 Fazen and Ringkamp, 2008; Kissin, 2008; Knotkova et al., 2008) . Despite extensive studies on the effects of perineural capsaicin treatment on the morphology, function and neurochemistry of primary afferent neurons, the mechanisms involved in the development of the antinociceptive actions of this treatment are still unclear. Previous studies have revealed a marked decrease in the sensitivity of C-fiber primary afferent neurons toward capsaicin following perineural capsaicin treatment (Jancso´and Lawson, 1990; Jancso´and Ambrus, 1994) . More recent studies indicate that this may be explained by massive reductions in the mRNA and protein expressions of the TRPV1 receptor, which confers capsaicin sensitivity on primary sensory neurons Caterina et al., 1997; Michael and Priestley, 1999) after perineural treatment with capsaicin (Szigeti et al., 2012) . Neuronal tract tracing and histochemical studies involving use of the cholera- toxin B subunit (CTB) conjugated with horseradish peroxidase (HRP) revealed that, unlike in control animals, injection of this tracer into a previously capsaicin-treated peripheral nerve resulted in marked transganglionic labeling not only of the deeper layers of the spinal dorsal horn, the termination sites of myelinated primary afferents, but also of the substantia gelatinosa, the main termination site of unmyelinated primary afferents. Since CTB and its conjugates are taken up and transported selectively only by myelinated primary afferent fibers in intact animals (Robertson and Grant, 1985; LaMotte et al., 1991; RiveroMelian and Grant, 1991) , the labeling of the substantia gelatinosa after perineural treatment with capsaicin was interpreted in terms of a sprouting response of A-fiber afferents (Mannion et al., 1996) . However, subsequent studies have revealed that, following peripheral nerve injury, e.g. nerve transection, not only myelinated A-fibers, but also unmyelinated nociceptive C-fibers take up and transport CTB and its conjugates (Tong et al., 1999; Bao et al., 2002; Jancso´et al., 2002 Sa´ntha and Jancso´, 2003; Shehab et al., 2003; Jancsoá nd Sa´ntha, 2004) . Electron microscopic studies have furnished direct evidence of the transport of CTB-HRP by unmyelinated dorsal root axons after peripheral nerve transection (Sa´ntha and Jancso´, 2003; . It has been concluded, therefore, that the increased labeling by transganglionically transported CTB or its conjugates of the substantia gelatinosa of the spinal dorsal horn after peripheral nerve transection may be explained by a phenotypic switch of nociceptive C-fiber primary sensory neurons rather than a sprouting response of myelinated primary afferents (Tong et al., 1999; Bao et al., 2002; Jancso´et al., 2002 Hughes et al., 2003; Sa´ntha and Jancso´, 2003; Shehab et al., 2003; .
CTB is a highly specific and sensitive biochemical marker of the GM1 ganglioside receptor (Cuatrecasas, 1973; Eidels et al., 1983) . Hence, the mechanisms underlying the increased transganglionic labeling of the substantia gelatinosa by CTB-HRP following perineural treatment with capsaicin may be of significance not only in terms of the anatomical changes which might occur after such treatment, but also as regards the possible functional significance of altered levels of neural gangliosides, and in particular GM1. Several lines of evidence indicate involvement of the GM1 ganglioside in nociceptive mechanisms. Besides its suggested role in opiate action (Crain and Shen, 1998) , the GM1 ganglioside has recently been shown to be an important regulator of neuronal capsaicin sensitivity and the expression of the TRPV1 receptor (Sa´ntha et al., 2010) .
The present study was therefore initiated to clarify the mechanism(s) contributing to the labeling of the substantia gelatinosa by peripherally injected CTB-HRP and to explore the possible implications of GM1 in vanilloid-induced nociceptor analgesia following perineural capsaicin treatment.
EXPERIMENTAL PROCEDURES
The experiments were approved by the Ethics Committee for Animal Care at the University of Szeged and were carried out in full accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC). All efforts were made to minimize animal suffering. The number of experimental animals was kept as low as possible.
Perineural treatment with TRPV1 agonists and labeling with CTB-HRP and WGA-HRP Adult male Wistar rats weighing 250-270 g at the start of the experiments were used in this study. The rats were anesthetized with chloral hydrate (400 mg/kg, i.p., Reanal, Budapest, Hungary). The sciatic nerves were exposed high in the thigh on both sides, and small pieces of gelfoam moistened with 0.1 ml of either a 1% solution of capsaicin (Fluka, Buchs, Switzerland) or a 0.005% solution of resiniferatoxin (Sigma-Aldrich GmbH, Steinheim, Germany) or the same volume of vehicle (6% ethanol, 8% Tween 80 in saline) were wrapped around the right and left nerves, respectively. After 20 min, the gelfoam pieces were removed, the wounds were closed, and the rats were returned to the animal house. After 14 days, the animals were anesthetized again, the sciatic nerves were exposed in the midthigh and 1 ll of a 1.5% solution of CTB-HRP or wheat germ agglutinin (WGA)-HRP conjugate (Sigma-Aldrich GmbH, Steinheim, Germany) was injected into each nerve via a Hamilton microsyringe. Three days after the injection of CTB-HRP or WGA-HRP, the animals were deeply anesthetized and perfused transcardially with an aldehyde fixative containing 1.25% glutaraldehyde and 1% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), followed by 400 ml of cold phosphate buffer containing 30% sucrose. The L4-L6 dorsal root ganglia and the L3-L6 segments of the lumbar spinal cord were removed and stored in the sucrose-buffer solution. Serial frozen sections of the dorsal root ganglia (DRGs) (15 lm in thickness) and the spinal cord (60 lm in thickness) were cut on a cryostat and a freezing microtome, respectively. Peroxidase activity was demonstrated by using 3,3 0 ,5,5 0 -tetramethylbenzidine (TMB, Sigma-Aldrich GmbH, Steinheim, Germany) as chromogen (Mesulam, 1978) .
Size-frequency distribution histograms of CTB-HRPlabeled neurons with clear-cut nuclei were generated by measuring their sizes in representative serial sections of the L5 DRGs of each animal by means of a light microscope equipped with a camera lucida and a digitizing tablet connected to a computerized system. The data are expressed as mean ± S.D. Statistical analysis of the data was performed with the Student t-test. p < 0.05 was regarded as a statistically significant difference between groups.
Demonstration of thiamine monophosphatase (TMP)
TMP activity was demonstrated essentially as described earlier (Inomata and Ogawa, 1979) , with some modifications to produce a reaction end-product of lead chromate instead of lead sulfide. Briefly, sections of the L4-L5 DRGs and the spinal cord were placed into an incubation solution containing 7.3 mM thiamine monophosphate (Sigma-Aldrich GmbH, Steinheim, Germany), 80 mM lead nitrate and 161 mM sucrose in Tris-maleate buffer (0.01 M, pH 5.4). After incubation at 37°C for 60-90 min, the sections were washed in Tris buffer and treated with 5% potassium bichromate for 5 min. The sections were then washed again, dehydrated, cleared with xylene and mounted with DePeX. The sections were viewed under a Leica DMLB (Leica Microsystems GmBH, Wetzlar, Germany) light microscope.
Consecutive representative sections of the spinal cord processed for the demonstration of TMP activity and the localization of CTB-HRP were used to assess the effectiveness of capsaicin treatment and for exact location of the somatotopically relating areas of the capsaicin-treated peripheral nerves within the spinal dorsal horn.
Electron microscopic histochemistry
The types of dorsal root afferents which transport CTB-HRP were identified at the ultrastructural level by using electron microscopic histochemistry. In 3 animals, the L5 dorsal roots, in which the majority (>80%) of the afferent fibers belongs to the sciatic nerve (Yip et al., 1984) , were ligated 12 h after the injection of CTB-HRP into the intact and capsaicin-treated nerves, respectively. Thirty-six hours later, the animals were perfused and the L5 dorsal roots were removed. Two-to-three millimeter segments were cut from the roots distal to the ligatures and peroxidase activity was demonstrated using TMB as a chromogen and tungstic acid as a stabilizer (Gu et al., 1992) . The samples were then reacted with diaminobenzidine and cobaltous chloride, postfixed with osmium tetroxide, dehydrated and embedded in Araldite. Ultrathin sections were cut on a Reichert Ultrotome, contrasted with uranyl acetate and lead citrate and viewed under a Jeol Jem 1010 (Jeol, Tokyo, Japan) electron microscope. Dorsal root axons were counted on screen in randomly selected sections.
RESULTS
Effects of perineural treatment with capsaicin or resiniferatoxin on the labeling of L5 DRG neurons with CTB-HRP injected into the sciatic nerve Injection of CTB-HRP into the sciatic nerve resulted in the labeling of many neurons in the L4-L6 spinal ganglia relating to the control and the capsaicin-treated sciatic nerves. Light microscopic inspection of specimens obtained from L4-L5 ganglia relating to capsaicin-or resiniferatoxin-treated sciatic nerves indicated a marked increase in the number of labeled small neurons as compared with the control (Fig. 1) . For quantitative assessment of the proportions and sizes of labeled neurons, quantitative morphometric measurements were performed in representative serial sections of the L5 DRGs, since about 80% of neurons in those DRGs send their axons into the sciatic nerve (Yip et al., 1984 ). An analysis of the size-frequency distribution histograms of the L5 DRG neurons revealed a pronounced increase in the number of labeled small neurons after perineural capsaicin or resiniferatoxin treatment (Fig. 2B-D) . In ganglia relating to the control nerve, small and large DRG neurons were labeled; the mean cross-sectional area of labeled neurons amounted to 943.2 ± 47.88 lm 2 . In the L5 spinal ganglia relating to the capsaicin and the resiniferatoxin-treated sciatic nerve, the proportion of small neurons increased significantly, resulting in a significant decrease in the mean neuronal cross-sectional area to 698.2 ± 27.59 lm 2 and 673.6 ± 43.44 lm 2 , respectively. In a previous study involving quantitative morphometry and a statistical approach, we could separate the large-and small-sized populations of DRG neurons; we demonstrated that, under the experimental conditions also used in the present study, neurons with crosssectional areas smaller or larger than 600 lm 2 can be classified as small and large neurons, respectively (Soares et al., 2002; Szigeti et al., 2012) . Statistical evaluation of the data revealed a significant increase in the proportion of small neurons from 44.0 ± 1.26% to 66.4 ± 0.64% and 65.6 ± 1.03% after perineural treatment with capsaicin and resiniferatoxin, respectively ( Fig. 2A) . These findings suggested a change in the phenotype of small neurons which acquired the ability to take up and transport CTB-HRP after capsaicin treatment, possibly due to an increase in their GM1 ganglioside level.
Effects of perineural treatment with capsaicin or resiniferatoxin on the labeling of the substantia gelatinosa with CTB-HRP injected into the sciatic nerve TMP histochemistry was used to identify the topographical distribution of sciatic primary afferent terminals affected by perineural treatment with the vanilloid compounds. In agreement with previous findings (Ainsworth et al., 1981; Gamse et al., 1982) , perineural application of capsaicin and resiniferatoxin resulted in an abolition of TMP activity from the somatotopically appropriate projection territories of the sciatic nerve in the substantia gelatinosa of the spinal dorsal horn (Fig. 3A, B, E, F) . In accord with previous findings, injection of CTB-HRP into a control sciatic nerve resulted in intense labeling of the somatotopically corresponding areas of the spinal dorsal horn, with the exceptions of the substantia gelatinosa and the marginal zone in the L3-L6 segments of the spinal cord (Fig. 3C, G) . This labeling pattern is characteristic of the distribution of thick myelinated primary afferent fibers in the dorsal horn (Szenta´gothai, 1964; Re´thelyi and Szenta´gothai, 1973; Brown, 1981; Willis and Coggeshall, 1991; Ramon y Cajal, 1995) . In agreement with previous findings (Mannion et al., 1996) , following the injection of CTB-HRP into a capsaicin-pretreated sciatic nerve, marked labeling was also observed in the somatotopically appropriate areas of the most superficial laminae of the spinal dorsal horn, the substantia gelatinosa and the marginal zone (Fig. 3D, H) . In the present study, similar results were obtained following treatment of the sciatic nerve with resiniferatoxin (Fig. 4) . These findings were unexpected, since the substantia gelatinosa is the main projection territory of unmyelinated primary afferents, and myelinated primary afferents do not normally terminate in this lamina. Effects of perineural treatment with capsaicin on the spinal distribution of unmyelinated sciatic primary afferents WGA and its conjugates are suitable tracer molecules with which to study the spinal distribution of unmyelinated primary afferent fibers. To evaluate possible structural alterations or changes in the projections of unmyelinated dorsal root fibers following perineural capsaicin treatment, therefore, the control and the capsaicin-treated sciatic nerves were injected with WGA-HRP. In control specimens, the peroxidase reaction product, indicating the presence of WGA-HRP, uniformly filled the substantia gelatinosa in a somatotopical manner throughout the L3-L6 segments of the spinal cord. Injection of this tracer into a capsaicin-treated nerve resulted in labeling of the substantia gelatinosa resembling that in the control in both topographical distribution and intensity (Fig. 5) .
Effects of perineural treatment with capsaicin on the axonal transport of CTB-HRP by myelinated and unmyelinated dorsal root axons
Electron microscopy revealed that many myelinated axons in the control L5 dorsal roots displayed a distinct electron-dense reaction product localized either to the axolemma or to the axoplasm, or both. Very few labeled unmyelinated axons were seen in the control dorsal roots (Fig. 6A, D) . The quantitative data disclosed that 50.6 ± 6% of the myelinated, but only 3 ± 1% of the unmyelinated dorsal root axons in the control dorsal roots transport CTB-HRP after injection into the sciatic nerve. Similarly, in the dorsal roots relating to the capsaicin-treated sciatic nerve, numerous myelinated axons contained electron-dense reaction product characteristic of HRP (Fig. 6E) . However, in contrast with the control, many unmyelinated dorsal root axons were also labeled with CTB-HRP. The reaction product was localized to both the axolemma and the axoplasm (Fig. 6B, C, E) . The quantitative data indicated that in the dorsal roots relating to the capsaicin-treated sciatic nerve, 57.2 ± 6.5% of the myelinated and 47.8 ± 6% of the unmyelinated axons transported the CTB-HRP conjugate. The difference between the proportions of labeled unmyelinated axons in the dorsal roots relating to the control and capsaicin-treated sciatic nerves was highly significant (p < 0.001, n = 3).
DISCUSSION
The present study confirms and extends earlier findings by revealing a massive labeling by transganglionically transported CTB-HRP of the somatotopically relating regions of the substantia gelatinosa of the spinal dorsal horn of a peripheral nerve treated perineurally with vanilloid compounds, but not with their solvents. Previous studies suggested that the increased labeling of the substantia gelatinosa with CTB-HRP injected into a capsaicin-treated nerve might be accounted for by the sprouting of intact myelinated primary afferents relating to the treated nerve into that area, which is normally served only by unmyelinated primary afferent fibers (Mannion et al., 1996) . The present study has confirmed this apparent ''sprouting phenomenon" after either perineural capsaicin or resiniferatoxin treatment. However, perineural treatment with capsaicin or resiniferatoxin also resulted in an increase in the proportion of CTB-HRPlabeled small DRG neurons. This may be explained by an increase in intraneuronal GM1 ganglioside, the molecular target of CTB, which is specifically bound by this ganglioside. Most importantly, the transport of CTB-HRP by unmyelinated dorsal root axons has been demonstrated directly with electron microscopic histochemistry, showing that a significant proportion of unmyelinated dorsal root axons contain CTB-HRP following perineural capsaicin treatment, whereas such labeled fibers are only rarely seen in dorsal roots relating to the control nerve. Collectively, these observations indicate that, following perineural treatment with the TRPV1 agonists capsaicin or resiniferatoxin, C-fiber primary afferent neurons undergo Injection of CTB-HRP into an intact nerve results in labeling of the deeper layers of the ipsilateral spinal dorsal horn (C, G), whereas after capsaicin treatment intense labeling is also present in the marginal zone and the substantia gelatinosa (D, H). Note the disappearance of thiamine monophosphatase activity in the substantia gelatinosa from the somatotopically appropriate regions of the sciatic nerve after capsaicin treatment (sites indicated by interconnected arrows). Also note that areas of CTB-HRP labeling of Rexed's laminae I-II are identical with sites of thiamine monophosphatase depletion as indicated by the interconnected arrows. The scale bar in H indicates 100 lm and holds for all microphotographs. a phenotypic switch and become capable of the uptake and transganglionic transport of CTB-HRP. This conclusion is supported by the finding that, similar to the control, injection of WGA-HRP into a capsaicin-treated sciatic nerve resulted in intense labeling of the somatotopically relating regions of the substantia gelatinosa, indicating the apparent anatomical integrity of unmyelinated primary afferents. This latter observation suggests that chemically injured unmyelinated primary afferents preserve their spatially constrained spinal terminal arborizations. Accordingly, the present results strongly suggest that the labeling of the substantia gelatinosa by CTB-HRP following perineural treatment with vanilloid compounds may be accounted for by a phenotypic switch of anatomically intact unmyelinated, C-fiber primary afferent neurons rather than a sprouting response of myelinated primary afferents. A similar conclusion was reached in earlier studies dealing with the consequences of peripheral nerve injuries, and in particular nerve transection, in terms of the transganglionic transport of CTB and its conjugates. These reports provided evidence in favor of the notion that, following transection of a peripheral nerve, CTB-HRP is taken up and, unlike in intact nerves, transported not only by myelinated, but also by unmyelinated primary afferents, and this may be responsible for the marked labeling of the substantia gelatinosa (Tong et al., 1999; Bao et al., 2002; Jancso´et al., 2002 Sa´ntha and Jancso´, 2003; Shehab et al., 2003; Jancsoá nd Sa´ntha, 2004) . Further, these studies have found little support for the suggested massive sprouting of myelinated primary afferent fibers into the substantia gelatinosa after peripheral nerve transection (Bao et al., 2002; Shehab et al., 2003) . This is also supported by the findings that, in the rat spinal dorsal horn, the plexus of vesicular glutamate transporter 1-immunoreactive boutons, which largely corresponds to the central terminals of large myelinated afferents, does not extend further dorsally after peripheral nerve transection (Hughes et al., 2004) . Although these findings clearly demonstrated that extensive sprouting of myelinated primary afferents which bind CTB is unlikely to occur, electrophysiological findings have revealed the sprouting of some myelinated mechanoreceptor primary afferents after peripheral nerve injuries (Woolf et al., 1992; Koerber et al., 1994; Kohama et al., 2000; Woodbury et al., 2008) . In view of the finding that a significant proportion of the small neurons is also labeled by CTB-HRP in control L5 ganglia, labeling of the substantia gelatinosa after perineural capsaicin may be effected by additional mechanisms affecting intraneuronal transport processes. It may be suggested that chemical perturbation of the sensory nerves by capsaicin interferes with mechanisms involved in regulation of the Fig. 4 . Inverse photomicrographs illustrating the effect of perineural treatment with resiniferatoxin on the distribution of labeled primary afferents in the 4th lumbar spinal cord segment of the rat. CTB-HRP was injected into the intact sciatic nerve (A) and into the contralateral sciatic nerve treated perineurally with resiniferatoxin 2 weeks previously (B). Note the massive labeling of the substantia gelatinosa (marked by arrowheads) following treatment with resiniferatoxin. The scale bar in B indicates 50 lm and holds for both microphotographs. cellular trafficking of specific molecules in primary sensory neurons. Hence, in neurons labeled by CTB-HRP in control ganglia, the perineural application of capsaicin may initiate changes resulting in spinopetal transport of tracer molecules toward the substantia gelatinosa. Further studies are needed to gain experimental support for this assumption.
The possible functional significance of the increased uptake and transport of CTB-HRP by unmyelinated primary afferent neurons following perineural treatment with capsaicin is difficult to envisage at present. Although CTB is largely regarded solely as a neuronal tracer, it is a highly specific biochemical marker for the GM1 ganglioside. It has therefore been suggested that the GM1 ganglioside may play a significant role in the function of nociceptive primary sensory neurons (Sa´ntha and Jancso´, 2003; . Indeed, it has been demonstrated that pharmacological manipulation of the neuronal GM1 ganglioside level of cultured adult dorsal root ganglion neurons interferes significantly with the nociceptor function. Inhibition of glucosylceramide synthase resulted in a reduced neuronal GM1 level and significant reductions in neuronal capsaicin sensitivity and TRPV1 expression (Sa´ntha et al., 2010) . Moreover, the acute sensitization of cultured nociceptive sensory ganglion cells by the nerve growth factor was inhibited after the depletion of neuronal gangliosides. Local regulatory (efferent) nociceptor functions were also affected, as revealed by a marked reduction of the capsaicin-, but not the high potassium-induced release of calcitonin gene-related peptide (CGRP) following the inhibition of glucosylceramide synthase. There are at least two possible mechanisms which may underlie these functional changes. First, the gangliosides, and in particular GM1, are involved in mediation of the effects of trophic factors such as the nerve growth factor, which in turn is essential in the regulation of the expression of the TRPV1 receptor in DRG neurons (Wood et al., 1988; Michael and Priestley, 1999) . A close association with and activation of the TrkA receptor by GM1 has also been reported and suggested to contribute to the mechanism of GM1 ganglioside potentiation of nerve growth factor (NGF) action (Leon et al., 1984; Mutoh et al., 1995; Duchemin et al., 2008; Ledeen and Wu, 2015) . Second, gangliosides are important constituents of membrane lipid rafts whose association with membrane receptors, including TRPV1, may play a significant role in the activation of that nociceptor channel (Sa´ntha and Jancso´, 2003; Liu et al., 2006; Sa´ntha et al., 2010; Szoke et al., 2010) . It has additionally been demonstrated that overexpression of the GM1 ganglioside suppressed nerve growth factor signals in PC12 cells (Nishio et al., 2004) , an observation that may explain the apparently contrasting cellular and functional changes brought about by perineural capsaicin treatment. Hence, a marked increase in neuronal GM1 ganglioside expression may impede nerve growth factor signaling and consequently the expression of TRPV1, which is critically dependent on nerve growth factor. A decrease in the expression level of the TRPV1 receptor may explain the impairment of nociceptive functions and the development of nociceptor analgesia observed after perineural capsaicin (Jancso´et al., 1980; Fitzgerald and Woolf, 1982) or resiniferatoxin (Kissin et al., 2002; Kissin, 2008) treatments. Indeed, recent findings furnished evidence of a decrease in TRPV1 mRNA and a massive permanent reduction in TRPV1 protein of DRG neurons following perineural treatment with capsaicin (Szigeti et al., 2012) .
The results of the present study have important implications as regards the possible anatomical and neurochemical hallmarks of neuropathic pain, an impaired sensory function and nociceptor analgesia. It appears that the changes demonstrated after peripheral nerve lesions or experimental perturbations in models of chronic/neuropathic pain and analgesia, respectively, are apparently identical or similar, at least at the phenomenological level. These alterations include decreases in the levels of sensory neuropeptides, e.g. substance P (SP) and CGRP, reduced expression of the TRPV1 receptor, depletion of TMP and reduction of Griffonia simplicifolia isolectin B4 (IB4) binding in the DRGs and the substantia gelatinosa (Jancso´, 1992; Fazen and Ringkamp, 2008; Sandkuhler, 2009; Kuner, 2010) . These findings clearly suggest that many of the anatomical and neurochemical changes believed to be specific for injuries of primary afferent neurons also occur after perineural treatment with capsaicin or resiniferatoxin, which induce selective regional chemical and thermal analgesia (Fitzgerald and Woolf, 1982; Gamse et al., 1982; Chung et al., 1985; Jancso´et al., 1987b) . This indicates that many of the cellular processes involved in the development of pain and analgesia may surprisingly, impact upon common cellular mechanisms. Hence, these anatomical and neurochemical alterations cannot be regarded as changes specific for peripheral nerve injuries. It must be noted that, although perineural treatment with vanilloid compounds may also cause certain changes which may be interpreted in terms of (chemical) nerve damage, these develop only after much longer post-treatment periods of several weeks (Jancso´and Lawson, 1990; Pini and Lynn, 1991) than the analgesia which develops within hours (Jancso´et al., 1980; Fitzgerald and Woolf, 1982) . In different models of neuropathic pain and vanilloid-induced nociceptor analgesia, respectively, axonal transport processes may be compromised (Gamse et al., 1982; Thakor et al., 2009; Dilley et al., 2013; Maiya and Messing, 2014) , resulting in a lack or decreased availability of trophic factors, such as the nerve growth factor. This may result, among others in the down-regulation of sensory neuropeptides and, importantly, nociceptor ion channels, such as the TRPV1 channel (Michael and Priestley, 1999; Szigeti et al., 2012) .
CONCLUSION
The present findings have provided evidence of a substantial, previously unrecognized phenotypic change of C-fiber primary sensory neurons following perineural treatment with vanilloid compounds that produce selective chemical and thermal analgesia. The results demonstrate that the increased labeling by CTB-HRP of the substantia gelatinosa after perineural capsaicin or resiniferatoxin treatment may be attributed to an increased uptake and transganglionic transport of CTB-HRP by C-fiber nociceptive primary afferent neurons rather than a sprouting response of myelinated primary afferents. It is further suggested that modulation of the expression of GM1 ganglioside in C-fiber nociceptive neurons may be of significance in terms of the regulation of the expression of the archetypal nociceptive ion channel, the TRPV1 receptor. It is assumed therefore that pharmacological manipulation of the neuronal GM1 ganglioside level may serve as a novel approach to regulation of the expression of nociceptive TRP channels and to pain relief.
